Page last updated: 2024-11-01

nortriptyline and Borderline Personality Disorder

nortriptyline has been researched along with Borderline Personality Disorder in 1 studies

Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.

Borderline Personality Disorder: A personality disorder marked by a pattern of instability of interpersonal relationships, self-image, and affects, and marked impulsivity beginning by early adulthood and present in a variety of contexts. (DSM-IV)

Research Excerpts

ExcerptRelevanceReference
"Risk factors such as borderline personality disorder and childhood abuse experiences were systematically assessed, and patients were genotyped for polymorphisms of GNbeta3."2.72Genetic, developmental and personality correlates of self-mutilation in depressed patients. ( Joyce, PR; Kennedy, MA; Luty, SE; McKenzie, JM; Miller, AL; Mulder, RT; Sullivan, PF, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Joyce, PR1
McKenzie, JM1
Mulder, RT1
Luty, SE1
Sullivan, PF1
Miller, AL1
Kennedy, MA1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Genetics of Self-injurious Behaviour[NCT05563324]234 participants (Actual)Observational2014-05-09Completed
Influences on and Prevention of Self-harm Behaviour Among the Most At-risk Adolescents[NCT05765864]400 participants (Anticipated)Observational2023-03-23Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for nortriptyline and Borderline Personality Disorder

ArticleYear
Genetic, developmental and personality correlates of self-mutilation in depressed patients.
    The Australian and New Zealand journal of psychiatry, 2006, Volume: 40, Issue:3

    Topics: Adolescent; Adult; Alleles; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricycl

2006
Genetic, developmental and personality correlates of self-mutilation in depressed patients.
    The Australian and New Zealand journal of psychiatry, 2006, Volume: 40, Issue:3

    Topics: Adolescent; Adult; Alleles; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricycl

2006
Genetic, developmental and personality correlates of self-mutilation in depressed patients.
    The Australian and New Zealand journal of psychiatry, 2006, Volume: 40, Issue:3

    Topics: Adolescent; Adult; Alleles; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricycl

2006
Genetic, developmental and personality correlates of self-mutilation in depressed patients.
    The Australian and New Zealand journal of psychiatry, 2006, Volume: 40, Issue:3

    Topics: Adolescent; Adult; Alleles; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricycl

2006